how to digest high volume yesterday. many ppl having big losses who chase high. expect to make decent profit from Tencent Partnership news catalyst.

If Tencent take up 10% GP private placement, what happen to his share price. As Tencent have selected GP as his Exclusive 10 years partnership for Cloud computing Business in Malaysia & other asia pacific region in future.

today GP share price over react .. many ppl in loss as speculative signing with Tencent will spur GP share price.finally not happen to limit up.

Once LTAT abandon privatisation of Boustead, share price shot up above RM1. as privatisation continue they will keeping 20% below his privatisation price of 0.80

share price trade higher after correction & consolidation, stay firm to ride higher again

Strongly believe with Cloud Business corporation will spur GP profitability in future. Tencent choice to alliance with GP, based on GP capablities

cloud business is big market opportunity. GP finally materialized the corporation with Tencent

any price below 0.20 still value buy..

PNB take up right issue of RM0.30

Titijaya limit up.. to whose hold titijaya

up limit

don't chase high .. buyback after share price retreat.

few million share buyback by STAR for price range of RM.38 - RM0.395

if privatisation materialised.. this will affect investor value where Boustead own good assets but manage by incapable person.

buy titijaya

RM4.70 a bit expensive to buy as compare to Dpharma. you should look M. Cap. Dpharma have bigger M.Cap.

last 2 days Pharma have flush weak holders & speculated. Indeed, share poised to trend up again as vaccine continue to issue good results.

STAR have transforming his traditional print Media to Digitalize business. Also strive to monetisation his assets (Property assets) which via JV & disposal. Currently Co. is seeking strategy business acquisition to foster his business profitability. as of today Star still continue declare dividend. indeed, the proceeds of assets disposal will use to declare special dividend as MCA needs money for imminent GE.

entrusted company must have capability & good background as vaccine is controlled product which involved public interest. how emerging company via JV & MOU can benefit with accredited by our government??

our Government in talk US & China, Malaysia to become Manfacturing Hub Covib19 Vaccine for Asia region. this is good indication as Dpharma with ready facilities certainly will benefit

that why Dpharma up so much. to produce Vaccine you need to accredited by authority. which Dpharma is poised to start production with spare capacity. Monday sure limit up again.

current share price RM0.365 + RM0.30 = RM 0.765 nor even his cash in hand + FOC for his business & assets without revalued worth more than RM600 Million. Good luck to those who invested & faith to Star

share with high safety of margin which his NTA RM1.10

legal tussle with Jack had drag STAR share price down. Great news court ruled RM134 mullions + 50 millions late interest which equivalent to 25 cents per share. currently cash in hand of RM0.52 + RM 0.25 =RM 0.77 cents per share. Star can declare special dividend to reward shareholders. Bear in mind late interest still continues until completion of development. each month delay is cost late interest of around RM 900K per month or RM10 millions per year. Monday limit up

vaccine needs government approval, company must well establish & good track records.

increasing interest & participating to joint development of vaccine is loom. pharma stock poised to go up

Glove stock fading ... pharma stock will replace.

time to buy

the boat is waiting weak holders to clear before trend up again, most you don't believe share will continue to go higher

collect & hold for 3 months

vaccine company is final winner for covib19 pandemic

during pandemic .. media consider essential services not big impact..

now print business have convert to digital ... assets will monetisation later declare dividend to rewards shareholders

something brewing... engine just start. TP 0.7

set up vaccine factory to produce vaccine for other countries

cash in hand at RM0.52 per share

glove stock fading ...gradually buying interest on Pharma

first target Price is RM 6

NotionVtec limit up

Good Dividend paymenf 0.18 cents

Monday limit up

TP : RM1 after RTO S5

now buyback again

sell to take profit

they request other corner investors to agree with such low offer price of RM0.80 whish his NTA above RM1.70

just buy & keep for 3 months

to firm out the privatisation... likely they need to renegotiate higher price to secure the deal..

any good news

Dpharma M.cap 2 x than Pharma.

better buy below 0.80